SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001367644-19-000019
Filing Date
2019-05-02
Accepted
2019-05-02 16:19:13
Documents
4
Period of Report
2019-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q12019pressrelease.htm 8-K 26370
2 EXHIBIT 99 q12019earningsrelease.htm EX-99 280175
3 a050221194qcy2018fina_image1.gif GRAPHIC 6381
4 a050221194qcy2018fina_image2.gif GRAPHIC 2966
  Complete submission text file 0001367644-19-000019.txt   320855
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 19792159
SIC: 2834 Pharmaceutical Preparations